ravulizumab
brolucizumab
pidilizumab
gevokizumab
ocrelizumab
hemagglutination
guselkumab
pozelimab
seroprotein
sintilimab
immunospecific
sasanlimab
zenocutuzumab
dinutuximab
toripalimab
retifanlimab
heterophilic
vanucizumab
ziltivekimab
serofast
solitomab
carlumab
immunoprobe
immunochromatographic
immunoglobulinemia
-umab
evolocumab
-mab
-a-
agonistic monoclonal antibody
immunodensity
monoantibody
polytypic
antiphospholipid antibody
antigenic
affinity
antiantibody
patritumab
serum globulin
-o-
antimonoclonal
paraimmunoglobulinopathy
immunocytometric
hematoimmune
immunocomplexemia
samalizumab
lymphoplasmacytic
immunoenrichment
serosuitable